Journal of the Neurological Sciences
Volume 313, Issue 1 , Pages 189-192, 15 February 2012

A novel nonsense mutation in the TITF-1 gene in a Japanese family with benign hereditary chorea

  • Katsuya Nakamura

      Affiliations

    • Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan
  • ,
  • Yoshiki Sekijima

      Affiliations

    • Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan
    • Division of Clinical and Molecular Genetics, Shinshu University Hospital, Japan
    • Corresponding Author InformationCorresponding author at: Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan. Tel.: +81 263 37 2673; fax: +81 263 37 3427.
  • ,
  • Kiyoshiro Nagamatsu

      Affiliations

    • Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan
  • ,
  • Kunihiro Yoshida

      Affiliations

    • Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan
  • ,
  • Shu-ichi Ikeda

      Affiliations

    • Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan

Received 9 June 2011; received in revised form 8 September 2011; accepted 13 September 2011. published online 07 October 2011.

Abstract 

A Japanese family with a novel nonsense mutation in the TITF-1 gene (p.Y98X) is described. The proband showed severe generalized chorea, delayed motor development, subnormal intelligence, congenital hypothyroidism, bronchial asthma, and a history of pulmonary infection, all of which are characteristic features of Brain–Thyroid–Lung syndrome. On the other hand, her brother and mother showed a mild benign hereditary chorea (BHC) phenotype with congenital hypothyroidism. Intrafamilial phenotypic variation is common in BHC/Brain–Thyroid–Lung syndrome and suggests the existence of other genetic or environmental factors regulating TITF-1 function. Although choreic movement in BHC/Brain–Thyroid–Lung syndrome is recognized as non-progressive, the proband showed re-exacerbation of choreic movement at puberty. The dopamine agonist, ropinirole hydrochloride, reduced her choreic movements, suggesting that levodopa and/or dopamine agonists may compensate for underdeveloped dopaminergic pathways in this disorder.

Keywords: Benign hereditary chorea (BHC), Brain–Thyroid–Lung syndrome, Thyroid transcription factor-1 (TITF-1), Chorea, Hypothyroidism, Nkx2.1

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-510X(11)00558-2

doi:10.1016/j.jns.2011.09.013

Journal of the Neurological Sciences
Volume 313, Issue 1 , Pages 189-192, 15 February 2012